Breast Cancer Vaccine-Recurrence Rates-Immune Response-Clinical Trial

Hybrid Vaccine Demonstrates Potential To Prevent Breast Cancer Recurrence

A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according to new research from a clinical trial led by researchers at The University of Texas MD Anderson Cancer Center... read more..

source:http://www.medicalnewstoday.com

National Health Care Issues-Health Care Reform-Washington, D.C.-Free Symposium-Cancer Care

Fighting a Smarter War Against Cancer: A Symposium

If you live in the Washington, D.C., area and are interested in national health care issues, from health care reform to navigating cancer care: what every patient needs to know, please consider attending the FREE symposium next week at Georgetown Lombardi Comprehensive Cancer Center: “Fighting a Smarter War Against Cancer: Linking Policy to the Patient.”  It’s a great lineup, [...] read more..